Litramine for Weight Loss
NCT02488356 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99
Last updated 2015-08-26
Summary
Safety and Efficacy of Litramine in weight loss.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Litramine
Sponsors & Collaborators
-
InQpharm Group
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2013-05-31
- Completion
- 2013-05-31
More Related Trials
-
Safety and Efficacy of IQP- AK-102 in Reducing Body Weight
NCT01905956 ·Status: COMPLETED ·Phase: PHASE3
-
Benefit and Tolerability of IQP-AE-103 in Weight Loss
NCT03058367 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
NCT04605861 ·Status: COMPLETED ·Phase: PHASE3
-
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
NCT02963935 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of IQP-VV-102 in Weight Management
NCT01681069 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
NCT04487743 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Determine the Effects of TM30339 on Weight Loss in Obese Individuals.
NCT00746824 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Libramed in Obesity Treatment
NCT03537235 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight
NCT06683508 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NGM395 in Adult Participants
NCT04187339 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
NCT03856047 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.
NCT00396448 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of IQP-AK-102 in Reducing Appetite
NCT02041754 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers
NCT03685656 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation
NCT01999764 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers
NCT00479492 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3537021 in Healthy Participants
NCT05444569 ·Status: COMPLETED ·Phase: PHASE1
-
Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine
NCT01184560 ·Status: COMPLETED ·Phase: NA
-
A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
NCT00189514 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
NCT00112021 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106
NCT05054530 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
NCT06124807 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3305677 in Participants With Obesity Or Overweight
NCT05623839 ·Status: COMPLETED ·Phase: PHASE1
-
A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese Subjects
NCT06040372 ·Status: COMPLETED ·Phase: PHASE1
-
An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers.
NCT06891287 ·Status: RECRUITING ·Phase: PHASE1